Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
Search
:::

齊振達 (Chen-Ta Chi)

齊振達(Chen-Ta Chi)圖 Return Appointment First Appointment

[Profile]

  • Education
    • M.D., Chung Shan Medical University, Taichung, Taiwan,
  • Career and Experience
    Current Positions：
    • - Now, Attending Physician, Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    • - Now, Instructor, National Yang-Ming Chiao-Tung University School of Medicine, Taipei, Taiwan,
    Experiences：
    • - , Chief Resident, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    • - , Resident, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
  • Medical Expertise
    1. viral hepatitis
    2. hepatocellular carcinoma
    3. ERCP
  • License
    Board-certified Physician, Diploma of Department of Health, Executive Yuan, Taiwan Board-certified Gastroenterologist and Instructor, Diploma of The Gastroenterological Society of Taiwan Board-certified Digestive Endoscopist and Instructor, Diploma of The Digestive Endoscopy Society of Taiwan

[Publications]

1. Comparable benefits of HCV eradication by direct acting antivirals and interferon-based therapy in patients with hepatocellular carcinoma undergoing surgical resection. Wu KC, Lee IC, Chi CT, Lei HJ, Chau GY, Yeh YC, Su CW, Huo TI, Chao Y, Lin HC, Hou MC, Huang YH. Am J Cancer Res. 2021 Nov 15;11(11):5526-5542. eCollection 2021.

2. Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection. Chi CT, Lee IC, Lee RC, Hung YW, Su CW, Hou MC, Chao Y, Huang YH. Cancers (Basel). 2021 Aug 27;13(17):4325. doi: 10.3390/cancers13174325.

3. Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven Criteria. Hung YW, Lee IC, Chi CT, Lee RC, Liu CA, Chiu NC, Hwang HE, Chao Y, Hou MC, Huang YH. Liver Cancer, 2021. doi: 10.1159/000517393. Epub 2021 July 22.

4. Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan. Chi CT, Chen CY, Su CW, Chen PY, Chu CJ, Lan KH, Lee IC, Hou MC, Huang YH. J Microbiol Immunol Infect. 2021 Jun;54(3):385-395. doi: 10.1016/j.jmii.2019.09.006. Epub 2019 Nov 14.

5. Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection. Chi CT, Chau GY, Lee RC, Chen YY, Lei HJ, Hou MC, Chao Y, Huang YH. J Formos Med Assoc. 2020 Jan;119(1 Pt 1):125-133. doi: 10.1016/j.jfma.2019.02.012. Epub 2019 Mar 12.

回到最上